Stockreport

Regeneron (NASDAQ:REGN) Reports Strong Q1 CY2026 [Yahoo! Finance]

Regeneron Pharmaceuticals, Inc.  (REGN) 
Last regeneron pharmaceuticals, inc. earnings: 2/6 06:30 am Check Earnings Report
US:NASDAQ Investor Relations: investor.regeneron.com
PDF Its non-GAAP profit of $9.47 per share was 6.4% above analysts' consensus estimates. Is now the time to buy Regeneron? Find out in our full research report Regeneron [Read more]